← Leaderboards
Willem Mulder
Icahn School Of Medicine At Mount Sinai
$11,953,843
Attributed
$14,929,491
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,929,491 · 8
By mechanism
R01$9,545,999 · 5
P01$5,383,492 · 3
Top collaborators
- Matthias Nahrendorf4 shared
- Zahi A. Fayad2 shared
- Carlos PãRez-Medina2 shared
- Thomas Reiner2 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Talia H Swartz$12,761,069
- Abraham Teunissen$2,813,520
- Jordi Ochando$5,634,948
- Mandy Maria Theresia Van Leent$2,578,599
- Ana Fernandez-Sesma$24,867,465
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageMouse ModelCellsIn VivoInflammationNanoparticleMonocyteMolecularInflammatoryImageMagnetic Resonance ImagingEventAtherosclerosisBaseSpecificityPreventRisk FactorsIn VitroLipidsDoseBiodistributionArterial Fatty StreakNanotherapyCardiovascular System
Grant awards (27)
Elucidating the role of trained immunity in kidney transplant patients$323,380
P01 · FY2025 · AI · contact PI
Stress-induced trained immunity in cardiovascular disease$505,804
P01 · FY2024 · HL · contact PI
Elucidating the role of trained immunity in kidney transplant patients$323,678
P01 · FY2024 · AI · contact PI
Stress-induced trained immunity in cardiovascular disease$534,579
P01 · FY2023 · HL · contact PI
Elucidating the role of trained immunity in kidney transplant patients$310,444
P01 · FY2023 · AI · contact PI
Translational imaging and nanomedicine in inflammatory atherosclerosis$680,250
P01 · FY2021 · HL · contact PI
Translational imaging and nanomedicine in inflammatory atherosclerosis$679,565
P01 · FY2020 · HL · contact PI
TRAF6 Nanoimmunotherapy to resolve plaque inflammation$816,219
R01 · FY2019 · HL · contact PI
PET nanoreporter image-guided breast cancer therapy$702,327
R01 · FY2019 · CA · contact PI
Translational imaging and nanomedicine in inflammatory atherosclerosis$679,567
P01 · FY2019 · HL · contact PI
TRAF6 Nanoimmunotherapy to resolve plaque inflammation$851,576
R01 · FY2018 · HL · contact PI
PET nanoreporter image-guided breast cancer therapy$758,800
R01 · FY2018 · CA · contact PI
Translational imaging and nanomedicine in inflammatory atherosclerosis$665,975
P01 · FY2018 · HL · contact PI
PET/MRI to study nanotherapy in atherosclerosis$590,721
R01 · FY2018 · HL · contact PI
Translational imaging and nanomedicine in inflammatory atherosclerosis$680,250
P01 · FY2017 · HL · contact PI
PET/MRI to study nanotherapy in atherosclerosis$590,721
R01 · FY2017 · HL · contact PI
Anti-inflammatory nanoparticle formulations to treat atherosclerosis$589,674
R01 · FY2017 · HL · contact PI
PET/MRI to study nanotherapy in atherosclerosis$590,721
R01 · FY2016 · HL · contact PI
Anti-inflammatory nanoparticle formulations to treat atherosclerosis$589,758
R01 · FY2016 · HL · contact PI
PET/MRI to study nanotherapy in atherosclerosis$582,671
R01 · FY2015 · HL · contact PI
Anti-inflammatory nanoparticle formulations to treat atherosclerosis$580,993
R01 · FY2015 · HL · contact PI
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy$351,713
R01 · FY2015 · CA · contact PI
Anti-inflammatory nanoparticle formulations to treat atherosclerosis$574,907
R01 · FY2014 · HL · contact PI
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy$341,162
R01 · FY2014 · CA · contact PI
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy$330,610
R01 · FY2013 · CA · contact PI
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy$351,713
R01 · FY2012 · CA · contact PI
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy$351,713
R01 · FY2011 · CA · contact PI